Friday, September 15, 2017

Cancer Gene Therapy - Table of Contents alert Volume 24 Issue 8

If you are unable to see the message below, click here to view.
Cancer Gene Therapy
TABLE OF CONTENTS

Volume 24, Issue 8 (August 2017)

In this issue
Original Articles
Short Communication

Also new
AOP
 
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Original Articles

Top

Association of long non-coding RNA H19 and microRNA-21 expression with the biological features and prognosis of non-small cell lung cancer

Y Zhou, B Sheng, Q Xia, X Guan and Y Zhang

Cancer Gene Ther 2017 24: 317-324; advance online publication, August 11, 2017; 10.1038/cgt.2017.20

Abstract | Full Text

shRNA-mediated silencing of hTERT suppresses proliferation and promotes apoptosis in osteosarcoma cells

P Chen, W-L Gu, M-Z Gong, J Wang and D-Q Li

Cancer Gene Ther 2017 24: 325-332; advance online publication, August 11, 2017; 10.1038/cgt.2017.22

Abstract | Full Text

Identification of breast cancer mechanism based on weighted gene coexpression network analysis

X Guo, H Xiao, S Guo, L Dong and J Chen

Cancer Gene Ther 2017 24: 333-341; advance online publication, August 11, 2017; 10.1038/cgt.2017.23

Abstract | Full Text

FBXO4 inhibits lung cancer cell survival by targeting Mcl-1 for degradation

C Feng, F Yang and J Wang

Cancer Gene Ther 2017 24: 342-347; advance online publication, August 4, 2017; 10.1038/cgt.2017.24

Abstract | Full Text

Enhancing the cytotoxicity of chemoradiation with radiation-guided delivery of anti-MGMT morpholino oligonucleotides in non-methylated solid tumors OPEN

P Ambady, Y J Wu, J M Walker, C Kersch, M A Pagel, R L Woltjer, R Fu, L L Muldoon and E A Neuwelt

Cancer Gene Ther 2017 24: 348-357; advance online publication, July 28, 2017; 10.1038/cgt.2017.27

Abstract | Full Text

Short Communication

Top

An AAVP-based solid-phase transducing matrix for transgene delivery: potential for translational applications OPEN

T L Smith, G R Souza, R L Sidman, W Arap and R Pasqualini

Cancer Gene Ther 2017 24: 358-360; advance online publication, May 26, 2017; 10.1038/cgt.2017.19

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature
 

No comments: